VEGF and its receptors are upregulated in other experimental animals and human type 1 and 2 diabetes, and inhibition of VEGF limits functional and structural alterations of the kidney in models of diabetic nephropathy [45], suggesting a deleterious role for VEGF in the pathophysiology of diabetic nephropathy [46]. The gene discussed is VEGFA; the disease is diabetic kidney disease.